TB-500 is defined, structurally, by a single continuous chain of 43 amino acids — the same sequence found in naturally occurring Thymosin Beta-4, reproduced synthetically rather than extracted from tissue. Understanding that structure is the starting point for interpreting almost everything else written about the compound, from how it is manufactured to how a given lot is verified.
Sequence and structural features
The Thymosin Beta-4 sequence is acidic, highly conserved across mammalian species, and — notably for a peptide this small — largely unstructured in solution rather than folding into a fixed tertiary shape. Its function depends less on a rigid structural fold and more on a specific stretch of residues responsible for actin binding, which is the structural feature most relevant to TB-500 research. The N-terminus of the natural protein is acetylated, a modification associated with resistance to rapid degradation by aminopeptidase enzymes; synthetic TB-500 preparations are typically produced to reflect that same feature, since an unprotected N-terminus can shorten a peptide's usable stability window in solution.
How TB-500 is manufactured
TB-500 is produced using solid-phase peptide synthesis, in which amino acids are added one at a time to a resin-bound chain, with protecting groups controlling which reactive sites participate at each step. Because the sequence runs a full 43 residues — long by the standards of most research peptides — synthesis, cleavage, and purification all require careful process control to avoid truncated or deletion sequences accumulating alongside the full-length product.
Purification and verification
After synthesis, the crude peptide is purified by reversed-phase HPLC to separate the target sequence from byproducts, then verified by mass spectrometry to confirm the measured mass matches the expected value for the TB-500 sequence. That two-step verification process is standard across the industry and is discussed in more depth in TB-500 purity testing.
Structural basis for its research role
The actin-binding region within this sequence is what connects TB-500's chemistry to its use in cell-migration and angiogenesis research — the functional consequences of that binding activity are covered in TB-500 mechanism of action. Characterized research material is available as part of the BPC-157 + TB-500 research stack.
Research Use Only. Supplied strictly for laboratory research and development — not for human or veterinary use, consumption, or any therapeutic or diagnostic purpose. This article is research education, not usage guidance.